Media Doctor Canada
  
Follow us on Twitter

Media

 

+

 

Doctor

 

Canada

"ASH: Diabetes risk slowed with angiotensin receptor blocker"


Medical Post

Source: Medical Post

Published: 21 Jun 2022

Category: Pharmaceutical

Rating: (2½ stars)

what they said (Hover the mouse cursor over underlined words for more info)

Researchers took a closer look at the massive data from a major clinical trial and found that receiving the angiotensin receptor blocker valsartan helped prevent hypertensives from developing diabetes.

"These new results should help physicians as they select anti-hypertensive agents for their patients, especially for those at higher risk of developing diabetes," said Dr. Kenneth Jamerson, a professor of internal medicine at the University of Michigan in Ann Arbor.

"Since we know from other studies that other hypertension medications such as diuretics come with a higher risk of diabetes, this result is especially interesting."

The original article can be found at: http://www.medicalpost.com/mpcontent/article.jsp?content=20050619_194619_5408

The original article can found in the Media Doctor archives.

how did it rate? (more information)

Criteria Rating
Total Score 4 of 9
Availability of Treatment Not Satisfactory (?)
Novelty of Treatment Satisfactory (?)
Disease Mongering Satisfactory (?)
Treatment Options Not Satisfactory (?)
Costs of Treatment Not Satisfactory (?)
Evidence Satisfactory (?)
Quantification of Benefits of Treatment Satisfactory (?)
Harms of Treatment Not Satisfactory (?)
Sources of Information Not Satisfactory (?)
Relies on Press Release Not Applicable
Quantification of Harms of Treatment Not Applicable

what we said (Hover the mouse cursor over underlined words for more info)

This article's key strength may be in the discussion of the evidence. Though not discussed specifically, the size and general characteristics of the study are disclosed.

The evidence is reported in both absolute and relative frames, or the absolute frame only, and rates with and without treatment. This, however, is not balanced by a discussion of rates of harm. Nor does the article make any attempt at independent corroboration of the evidence.

public forum

There are currently no comments on this article.

voice your opinion in the forum

  • All comments and feedback submitted to Media Doctor are subject to editorial approval before being made viewable by the public. It may take up to a week for your comments to be approved. Additionally, no response will be given to questions posed in public comments. Media Doctor does not provide medical advice, or answers to medical questions posed by the public.
  • If you provide your email address it will not be displayed to the general public.
  • Comments may be edited by Media Doctor to remove defamatory or sensitive statements, and brand names.
  • Required fields are marked with an asterisk (*).
Name: *
Organisation:
Email:
Comments: *
Copyright © Media Doctor Canada